Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-16

Clinical Trial Update: Probiotic (VSL #3) for Gulf War Illness [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for probiotic VSL #3 in Gulf War Illness shows termination with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VSL#3

Snippet

Sponsor: University of Utah | Conditions: Gulf War Illness | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-01-16